-[5''-O-(2-cyanoethyl-N,N-diisopropylphosphoroamidite)pentyl] inosine (7)
Compound 5 (70 mg, 0.18 mmol) was coevaporated with anhydrous benzene (3 × 1 mL) and then dissolved in anhydrous THF (1.0 mL). To this solution DIPEA (0.040 mL, 0.21 mmol) and then (iPr) 2 NP(OCE)Cl (0.050 mL, 0.21 mmol) were added and the mixture was stirred at room temperature for 1 h. After the completion of the reaction (TLC monitoring: hexane/AcOEt, 6:4), the mixture was diluted with AcOEt (10 mL) and extracted with buffer phosphate solution at pH 7 (2 × 10 mL). The organic layer was separated and dried over anhydrous Na 2 SO 4 . The solvent was evaporated under reduced pressure and the crude was purified over 2% KOH coated silica gel column eluted with increasing amounts of AcOEt in hexane (from 20 to 40%). The fractions were collected and the solvents removed under reduced pressure, affording pure compound 7 (75 mg, 70%) as a 1:1 mixture of diastereomers. 
Oil

2',3'-O-Isopropylidene-N 1 -[5''-O-(bis(2-cyanoethyl)phosphate)pentyl] inosine (9)
Compound 5 (70 mg, 0.18 mmol) was coevaporated with anhydrous benzene (3 × 2 mL) and then dissolved in anhydrous THF (1.0 mL). To this solution (iPr) 2 NP(OCE) 2 (57 mg, 0.21 mmol) and 1H-tetrazole (38 mg, 0.54 mmol) were added and the mixture was stirred at room temperature for 2 h. After the completion of the reaction (TLC monitoring: CHCl 3 /CH 3 OH, 9.5:0.5), t-BuOOH (5.5 M in decane, 0.33 mL, 1.8 mmol) was added and the reaction was stirred for 2 h at room temperature (TLC monitoring: AcOEt/CH 3 OH, 8.5:1.5). The solvents were evaporated under reduced pressure and the crude product was purified over a silica gel column eluted with increasing s3 amounts of CH 3 OH in AcOEt (from 0 to 5%). The fractions were collected and the solvents removed under reduced pressure, affording the pure compound 9 (71 mg, 68% over two steps). 3, 149.7, 148.6, 141.3, 125.3, 118.5, 115.3, 92.4, 88.5, 85.9, 82.9, 69.9, 64.3, 63.3, 47.7, 30.6, 30.5, 30.0, 27.5, 25.3, 23.5, 20.2, 20 149.9, 149.5, 148.8, 141.2, 135.6, 124.9, 123.9, 118.6, 115.0, 92.7, 88.4, 86.2, 83.5, 69.5, 64.1, 63.3, 47.5, 30.9, 30.4, 30.2, 27.3, 25.4, 23.5, 20 
2',3'-O-Isopropylidene-N 1 -(5''-O-phosphatepentyl)inosine (11)
Compound 9 (50 mg, 0.086 mmol) was dissolved in methanol/concentrated aqueous ammonia (1:1, 1.0 mL) and the reaction was allowed to stir at 50 °C for 16 h (TLC monitoring:
isopropanol/ammonia/water, 6:3:1). The solvents were removed under reduced pressure and the crude was purified by a C-18 reversed-phase silica gel column, with increasing amount of CH 3 OH s4 in water (from 0 to 50%). The fractions were collected and the solvents removed under reduced pressure, affording pure compound 11 (30 mg, 72%) as ammonium salt. 9, 148.7, 147.3, 140.3, 123.7, 114.9, 90.3, 86.5, 83.6, 80.9, 80.7, 65.3, 61.4, 47.5, 29.3, 29.2, 28.4, 25.9, 24 
5'-O-tert-Butyldimethylsilyl-2',3'-O-isopropylidene-1-(2,4-dinitrophenyl)inosine(13)
To a solution of 12 (1.2 g, 2.8 mmol) in DMF (12 mL), K 2 CO 3 (1.56 g, 1.1 mmol) and 2,4-dinitrochlorobenzene (2.3 g, 1.1 mmol) were added and the reaction was stirred for 4 h at 80 °C (TLC monitoring CHCl 3 /MeOH, 9.5:0.5). The solvent was evaporated under reduced pressure and the crude was purified over a silica gel column eluted with increasing amounts of CH 3 OH in CHCl 3
(from 0 to 5%). The fractions were collected and the solvents removed under reduced pressure, affording pure compound 13 (1.0 g, 63%). 147.0, 145.1, 139.0, 135.6, 132.9, 128.9, 124.3, 121.3, 114.3, 114.1, 92.0, 91.4, 87.5, 87.0, 85.7, 81.3, 63.6, 27.2, 25.8, 25.3, 18.3, -5 To a solution of 13 (0.50 g, 0.85 mmol) in DMF (2.0 mL) 5-amino-1-pentanol (0.90 g, 8.5mmol) was added and the mixture was stirred at 50 °C for 16 h (TLC monitoring CHCl 3 /MeOH, 9.5:0.5).
The solvent was evaporated under reduced pressure and the crude was purified over a silica gel column eluted with increasing amounts of CH 3 OH in CHCl 3 (from 0 to 5% 
5'-O-tert-Butyldimethylsilyl-2',3'-O-isopropylidene-N 1 -(5-acetoxypentyl)inosine (15)
Compound 14 (0.33 g, 0.65 mmol) was dissolved in a mixture of Ac 2 O-pyridine (1:1, 2.0 mL) and the solution was kept at room temperature for 2 h (TLC monitoring: CHCl 3 /MeOH, 9.5:0.5).The solvents were evaporated under reduced pressure to give compound 15 (0.35 g, 99%) that was used for the next synthetic step without purification. 5, 157.9, 149.7, 149.4, 148.3, 140.75, 125.2, 114.9, 92.3, 88.8, 86.0, 82.7, 65.1, 64.6, 47.5, 30.2, 29.1, 27.5, 26.3, 25.5, 23.8, 22.0, 20.8, 20.8, 19.0, -5 
2',3'-O-Isopropylidene-N 1 -(5-acetoxypentyl)inosine (16)
Compound 15 (0.30 g, 0.54 mmol) was dissolved in MeOH (10 mL) and then NH 4 F (0.40 g, 11 mmol) was added. The reaction was refluxed for 16 h (TLC monitoring: CHCl 3 /MeOH, 9.5:0.5).
The solvent was evaporated under reduced pressure and the crude was purified over a silica gel s6 column eluted with increasing amounts of CH 3 OH in CHCl 3 (from 0 to 10% 
2',3'-O-Isopropylidene-N 1 -(5-acetoxypentyl)inosine 5'-bis(2-cyanoethyl) phosphate (17)
Compound 16 (0.20 g, 0.46 mmol) was coevaporated with anhydrous benzene (3 x 2 mL) and then dissolved in anhydrous THF (4.0 mL). To this solution (iPr) 2 NP(OCE) 2 (0.25 g, 0.92 mmol) and tetrazole (0.10 g, 1.4 mmol) were added and the mixture was stirred at room temperature for 2 h.
After the completion of the reaction (TLC monitoring: CHCl 3 /CH 3 OH, 9.5:0.5), t-BuOOH (5.5 M in decane, 0.80 mL, 4.6 mmol) was added and the reaction was stirred for 2 h at room temperature (TLC monitoring: CHCl 3 /CH 3 OH, 9.5:0.5). The solvents were evaporated under reduced pressure and the crude was purified over a silica gel column eluted with increasing amounts of CH 3 OH in 5, 158.1, 149.4, 148.1, 141.5, 125.6, 118.5, 115.5, 92.4, 88.6, 85.7, 82.5, 66.8, 64.9, 62.6, 47.7, 30.3, 29.5, 27.7, 25.4, 22.7, 20. 148.7, 147.3, 140.3, 123.7, 114.9, 90.3, 86.5, 83.6, 80.9, 80.7, 65.3, 61.4, 47.5, 29.3, 29.2, 28. 
2',3'-O-isopropylidene-N 1 -pentylinosine cyclic 5',5''-phosphate (19)
Compound 18 (20 mg, 0.040 mmol) was dissolved in DMF (20 mL) and then EDC (9.6 mg, 0.050 mmol) was added. The reaction was allowed to stir for 48 h at room temperature (TLC monitoring:
isopropanol/ammonia/water, 6:3:1). After removing the solvent under reduced pressure, the crude was dissolved in 1 mL of TEAB 0.1 M and then purified by HPLC (see General). The fractions containing the title compound were collected, concentrated and finally lyophilized to afford compound 19 (6.6 mg, 30%) as triethylammonium salt. 7, 148.5, 147.6, 140.2, 122.9, 115.2, 90.1, 86.7, 83.4, 80.7, 65.3, 64.7, 47.2, 29.1, 28.6, 28.4, 25.7, 24.1, 22. 9, 149.9, 148.2, 140.2, 122.7, 88.5, 83.9, 74.6, 69.9, 65.0, 64.5, 47.4, 30.7, 28.3, 22. 
